- Top of page
- MINIMAL REQUIREMENTS FOR SETTING 1
- STAGING OF THE TUMOR
- SUPPORTIVE CARE
- MAIN ACUTE SIDE EFFECTS OF CHEMOTHERAPY AGENTS
- SPECIAL CLINICAL PROBLEMS
Treatment recommendations for endemic Burkitt lymphoma (BL) in settings with only minimum requirements for curative treatment (PODC setting 1) are described. The reported cure rate for endemic BL is usually <50%. Facilities within setting 1 differ. Three treatment schedules are proposed based on: (1) when accurate staging is not possible, (2) when staging is possible and for (3) relapses and poor responders to primary therapy. A literature review and personal experience were used to formulate the recommendations. Recorded 1-year event free survival was 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment. Pediatr Blood Cancer 2013; 60: 357–362. © 2012 Wiley Periodicals, Inc.